MeMed logo

MeMed is transforming patient care by listening to the immune system and turning host response signals into clinical action.

MeMed BV

We developed a pioneering test to help physicians with the seemingly simple clinical dilemma - is it a bacterial or viral infection? 

By providing host response information, we help physicians make more informed decisions about how and when to treat. From a small serum sample, MeMed BV computationally integrates the level of three host immune proteins into a simple score indicating the likelihood of a bacterial immune response or co-infection versus a likely virtual immune response.

MeMed product_JPG.webp

The Host Immune Response Can Overcome Limitations of Current Diagnostic Challenges

icon.png

Inaccessible infection sites

icon3.png

Often no pathogens are detected

icon2.png

​False alarms due to colonization

icon4.png

Prolonged time to results

Corona icon.png

Uncertainty regarding severity

MeMed Key

A cutting-edge technology, compact, multi-purpose platform quantitative diagnostic immunoassays that open the way to central lab performance at the point of need, using chemiluminescence detection technology.
MeMed Key runs the MeMed BV™ test within 15 minutes.

*MeMed BV® test and the MeMed Key® platform, have both been granted 510(k) clearance by the U.S. @FDA

About MeMed

At MeMed, a leader in host response technologies, we decode the body's complex signals into simple insights that improve people's lives. By leveraging our expertise in host-response profiling and machine-learning algorithms, we are creating a portfolio of tests that address tough clinical dilemmas.

a9d1dd_f86b8a8c42534cf7953ee4cbc5f5c9a9_mv2_d_1800_1200_s_2.webp

Clinical Evidence

MeMed BV’s high performance has been validated, tested and used on more than 20,000 patients.

Click to read the full articles here:

lancet_infectious_diseases.png
the_plos_2_.png
logo_3_.png
A girl talking on the phone

Contact us